Last: | $210.59 |
---|---|
Change Percent: | -0.18% |
Open: | $213.52 |
Close: | $210.59 |
High: | $213.52 |
Low: | $208.19 |
Volume: | 730,352 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$210.59 | $213.52 | $210.59 | $213.52 | $208.19 | 730,352 | 05-17-2024 |
$213.13 | $212.96 | $213.13 | $215.07 | $212.29 | 676,626 | 05-16-2024 |
$213.21 | $212.26 | $213.21 | $213.78 | $210.835 | 540,467 | 05-15-2024 |
$211.2 | $211.34 | $211.2 | $212.16 | $208.6804 | 536,448 | 05-14-2024 |
$210.37 | $208.31 | $210.37 | $211.4 | $207.8451 | 792,854 | 05-13-2024 |
$207.67 | $206.34 | $207.67 | $207.8 | $205.46 | 722,931 | 05-10-2024 |
$206.15 | $201.53 | $206.15 | $206.23 | $201.47 | 813,688 | 05-09-2024 |
$201.61 | $202.33 | $201.61 | $202.33 | $200.68 | 556,184 | 05-08-2024 |
$201.5 | $201.99 | $201.5 | $202.5355 | $199.615 | 620,897 | 05-07-2024 |
$201.04 | $202.41 | $201.04 | $203.09 | $199.385 | 813,044 | 05-06-2024 |
$201.32 | $201.12 | $201.32 | $202.92 | $199.68 | 555,654 | 05-03-2024 |
$200.25 | $201.57 | $200.25 | $201.645 | $199.11 | 599,282 | 05-02-2024 |
$201.32 | $200.76 | $201.32 | $204.09 | $198.43 | 765,348 | 05-01-2024 |
$201.37 | $203.21 | $201.37 | $204.5 | $200.925 | 887,186 | 04-30-2024 |
$204.17 | $199 | $204.17 | $207.535 | $199 | 1,394,991 | 04-29-2024 |
$198.4 | $197.08 | $198.4 | $200.155 | $197.01 | 931,317 | 04-26-2024 |
$198.35 | $204.77 | $198.35 | $204.82 | $196.11 | 2,097,329 | 04-25-2024 |
$207.94 | $206.82 | $207.94 | $208.14 | $205.54 | 793,521 | 04-24-2024 |
$207.97 | $204.76 | $207.97 | $210.63 | $203.22 | 925,458 | 04-23-2024 |
$203.07 | $202.25 | $203.07 | $203.89 | $200.67 | 685,960 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Laboratory Corporation of America Holdings Company Name:
LH Stock Symbol:
NYSE Market:
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy PR Newswire Labcorp is now the only lab that can detect preeclampsia risk across all pregnancy trimesters BURLINGTON, N.C. , May 15, 2024 /PRNewswire/ -- Labc...
Invitae Receives Court Approval for Sale to Labcorp PR Newswire Acquisition advances Labcorp's specialty testing strategy in key areas such as oncology and rare diseases Key milestone reached in Invitae's Chapter 11 process BURLINGTON, N.C. and...
Revealing a significant insider sell on May 1, Peter J Wilkinson, SVP at Laboratory Corp (NYSE:LH), as per the latest SEC filing. What Happened: Wi...